Article
Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma
29 Aug 2025
Abstract excerpt
High-risk (HR) neuroblastoma (NBL) patients often receive standardized treatment despite wide variations in clinical outcomes, underscoring the need for improved stratification tools. A distinguishing feature of NBL is the patient-specific expression of gangliosides (GGs), particularly GD2, which may serve as biomarkers. We analyzed GG profiles in 18 patient-derived tumors and 11 NBL cell lines using thin-layer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
